PROFORMANT publishes its Pulmonary Biopharma Outlook. more PROFORMANT publishes Specialty Pharmaceutical Franchise Strategy. more PROFORMANT achieves $50B milestone. more Mass Opportunities: A Biotechnology Investor Conference more Biobusiness 2005 more BIO CEO & Investor Conference more Pulmonary Biopharma Outlook. more Biomedical Valuation: Contemporary Methods and Practice. more